本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oric Pharmaceuticals Inc.

12.06
-0.3200-2.58%
盤後12.300.2400+1.99%19:20 EDT
成交量:134.71萬
成交額:1,624.27萬
市值:12.10億
市盈率:-8.20
高:12.74
開:12.13
低:11.76
收:12.38
52周最高:14.93
52周最低:3.90
股本:1.00億
流通股本:8,654.55萬
量比:0.75
換手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):-1.4700
每股收益(LYR):-1.4747
淨資產收益率:-41.27%
總資產收益率:-26.17%
市淨率:3.15
市盈率(LYR):-8.18

資料載入中...

2025/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/28

重要事件披露

Form 8-K - Current report
2025/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/14

重要事件披露

Form 8-K - Current report
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/19

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]